|
Putative [Eubacterium] rectale NB2A-17-FMU RM systems
Ref: Spreafico,A. et al. Nat Cancer (2022) In press
REBASE ref # 34529
Complete sequence: 2,804,625 bp
GenBank #: CP100127
REBASE acronym: EreFMU
Org_num: 60205
All begin NKF89_
Type I | ||||
---|---|---|---|---|
ORF | Gene | Most similar | Specificity | Name |
4220 | alpha/beta hydrolase | |||
4225 | M | M.Lba2492ORFJP (99% identity) | M.EreFMUORF4225P | |
4230 | S | S2.Lba2492ORFJP (53% identity) | S1.EreFMUORF4225P | |
4235 | nucleotidyltransferase domain-containing | |||
4240 | nucleotidyltransferase substrate binding | |||
4245 | tyrosine-type recombinase/integrase | |||
4250 | S | S3.PmeBin109ORFCP (41% identity) | S2.EreFMUORF4225P | |
4255 | ATP-binding protein | |||
4260 | R | Lba2492ORFJP (99% identity) | EreFMUORF4225P | |
4265 | cysteine hydrolase | |||
Type II | ||||
ORF | Gene | Most similar | Specificity | Name |
1765 | 92 aa hypothetical protein | |||
1770 | M | M.PmeBin285ORFBP (100% identity) | M.EreFMUORF1770P | |
1775 | 111 aa hypothetical protein | |||
11860 | 288 aa hypothetical protein | |||
11865 | M | M.Mfo14469aORF13325P (90% identity) | M.EreFMUORF11865P | |
11870 | R | R2.Mfo14469aORF13325P (86% identity) | R1.EreFMUORF11865P | |
11875 | R | R1.Mfo14469aORF13325P (92% identity) | R2.EreFMUORF11865P | |
11880 | V | V.FspQ4148ORF9535P (96% identity) | V.EreFMUORF11865P | |
11885 | MFS transporter | |||
12905 | 121 aa hypothetical protein | |||
12910 | V | V.Are8ORF1660P (98% identity) | V.EreFMUORF12920P | |
12915 | R | Are8ORF1660P (98% identity) | EreFMUORF12920P | |
12920 | M | M.Are8ORF1660P (98% identity) | M.EreFMUORF12920P | |
12925 | 547 aa hypothetical protein | |||
Type IV | ||||
ORF | Gene | Most similar | Specificity | Name |
13100 | SPFH domain-containing protein | |||
13105 | R | Blu17040ORF22870P (74% identity) | EreFMUORF13105P | |
13110 | methyltransferase domain-containing protein |